Evidence map›Paper›PMID 30283363›Full record

ArticleFrontiers in psychiatry2018

Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis.

Saeed Ahmed, Sanya Virani, Vijaya P Kotapati, Ramya Bachu, Mahwish Adnan, Ali M Khan, Aarij Zubair, Gulshan Begum, Jeevan Kumar, Mustafa Qureshi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 3 countries.

Saeed AhmedNassau University Medical Center, East Meadow, NY, United States.
Sanya ViraniMaimonides Medical Center, New York, NY, United States.
Vijaya P KotapatiManhattan Psychiatric Center, New York, NY, United States.
Ramya BachuZucker Hillside Hospital, New York, NY, United States.
Mahwish AdnanDepartment of Cognitive Behavioral Science, McMaster University, Hamilton, ON, Canada.
Ali M KhanDepartment of Psychiatry, University of Texas Rio Grande Valley, Harlingen, TX, United States.
Aarij ZubairSt. John's University, New York, NY, United States.
Gulshan BegumManhattan Psychiatric Center, New York, NY, United States.
Jeevan KumarBolan Medical College, Quetta, Pakistan.
Mustafa QureshiTexas Tech University Health Sciences Center, Lubbock, TX, United States.
Rizwan AhmedLiaquat National Medical College, Karachi, Pakistan.
Manhattan Psychiatric Center · USBolan Medical College · PKLiaquat National Hospital · PKMaimonides Medical Center · USMcMaster University · CANassau University Medical Center · USSt. John's University · USTexas Tech University · USThe University of Texas Rio Grande Valley · USZucker Hillside Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cigarettesnicotine addictionschizophreniasmoking cessationvarenicline

Identifiers

PMID30283363
PMCPMC6156523
OpenAlexW2889207821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.